Man Group
QTTB icon

Man Group’s Q32 Bio QTTB Stock Holding History

Man Group’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-738
Closed -$21K – 2275
2022
Q3 		$21K Buy
+738
New +$30.1K ﹤0.01% 1935

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Man Group's QTTB Position: Q4 2022 in Review

Man Group sold out of Q32 Bio (QTTB) in Q4 2022, closing a stake of 738 shares — an estimated $21K sold.

Man Group first reported a position in QTTB in Q3 2022 and held it in 1 quarter. The position peaked at $21K in Q3 2022. 79 funds tracked by Wall St. Rank hold QTTB as of Q4 2022.

  • Man Group reported no remaining Q32 Bio position as of Q4 2022 after selling out during the quarter.
  • Man Group sold 738 Q32 Bio shares in Q4 2022, an estimated $21K.
  • Man Group first reported a position in Q32 Bio in Q3 2022 and held it in 1 quarter.
  • Man Group's Q32 Bio position peaked at $21K in Q3 2022.
  • 79 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.